PIXL BIO

Techbio 2.0

This company develops induced pluripotent stem cell models and artificial intelligence platforms to provide predictive drug discovery data for pharmaceutical and biotechnology researchers.

iOrganBio

This company develops an artificial intelligence-guided manufacturing platform to produce engineered human cells and organoids for biopharmaceutical researchers and clinical partners.

Cellbox Labs

This company develops automated organ-on-chip platforms for pharmaceutical firms to perform precise drug discovery and testing without using animal models.

Oscillution

This company provides in vitro human brain cell models and testing platforms to pharmaceutical and biotech firms for drug discovery and safety assessment.

Axiom Bio

This company develops artificial intelligence models that predict drug toxicity to help pharmaceutical researchers identify safety risks early in the development process.

Greenstone Biosciences

This company provides stem cell-derived models and artificial intelligence platforms to pharmaceutical companies and academic researchers for drug discovery and toxicity testing.

Parallel Bio

This company develops a drug discovery platform using human immune organoids and artificial intelligence for pharmaceutical and biotechnology partners.

MeOmics

The company develops a precision psychiatry platform using patient-derived stem cells and AI to help drug developers accelerate psychiatric medicine discovery.